Michael Caligiuri

Title(s)Emeritus Professor, Psychiatry
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Overview 
    Collapse Overview

    Biography

    Dr. Caligiuri attended the University of Wisconsin, Madison where he received a Ph.D. in neuroscience with an emphasis in motor control. His current research focuses on motor control in neuropsychiatric disorders, developing quantitative instrumentation for assessing dyskinesia and parkinsonism, and understanding the interplay between neuromotor dyscontrol and psychiatric illness. Particular emphasis is placed on validating measures of handwriting kinematics for quantitative assessment of neuropsychiatric movement disorders.

    Research Interests

    Dr Caligiuri’s research focuses on understanding how motor function and impairment can be useful in the diagnosis and treatment of affective and psychotic illnesses. Significant research contributions include: the demonstration that early drug-induced parkinsonism can predict long-term persistent movement disorders in patients treated with antipsychotics; finding that affective state in bipolar disorder may be related to a disturbance of inhibitory regulation within the basal ganglia and that antipsychotics and or mood stabilizers normalize cortical and subcortical hyperactivity in patients with bipolar disorder; development of a portable, simple to use transducer for quantifying tremor; and demonstrating that measures of handwriting kinematics can detect subtle differences in EPS liability between various antipsychotic medications. His current research aims to understand the effects of drugs, disease, and aging on handwriting kinematics to enable the forensic community to better understand these contributions when authenticating signatures.

    Clinical Focus

    Dr. Caligiuri’s clinical focus is on movement disorders with particular emphasis of differentiating idiopathic or degenerative disorders from medication-induced disorders and developing technologies for the rapid quantification of extrapyramidal motor signs such as tremor, dyskinesia and bradykinesia.

    Collapse Research 
    Collapse Research Activities and Funding
    Enhancing NK Cell Activity by Dietary Diphyllin Lignans for Cancer Prevention
    NIH R01CA185301Dec 18, 2014 - Dec 31, 2019
    Role: Co-Principal Investigator
    EPS AND PREDICTORS OF PSYCHOSIS IN ALZHEIMERS DISEASE
    NIH R01AG014291Sep 30, 1996 - Aug 31, 2002
    Role: Principal Investigator
    QUANTITATIVE STUDIES OF NEUROLEPTIC-INDUCED PARKINSONISM
    NIH R29MH045959Apr 1, 1991 - Mar 31, 1996
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Graphomotor Dysfluency as a Predictor of Disease Progression in Premanifest Huntington's Disease. J Huntingtons Dis. 2023; 12(3):283-292. Caligiuri M, Culbert B, Prasad N, Snell C, Hall A, Smirnova A, Churchill E, Corey-Bloom J. PMID: 37182891.
      View in: PubMed   Mentions:    Fields:    
    2. Handwriting Kinematics in Patients with Schizophrenia Treated with Long-Acting Injectable Atypical Antipsychotics: Results From the ALPINE Study. Schizophr Bull Open. 2022 Jan; 3(1):sgac018. Caligiuri MP, Weiden PJ, Legedza A, Yagoda S, Claxton A. PMID: 39144789; PMCID: PMC11205961.
      View in: PubMed   Mentions:
    3. Elucidating the relationships between two automated handwriting feature quantification systems for multiple pairwise comparisons. J Forensic Sci. 2022 Mar; 67(2):642-650. Fuglsby C, Saunders C, Ommen DM, Buscaglia J, Caligiuri MP. PMID: 34634133.
      View in: PubMed   Mentions: 2     Fields:    
    4. Advances toward validating examiner writership opinion based on handwriting kinematics. Forensic Sci Int. 2021 Jan; 318:110644. Ommen DM, Fuglsby C, Caligiuri MP. PMID: 33310531.
      View in: PubMed   Mentions: 1     Fields:    
    5. Use of an Automated System to Evaluate Feature Dissimilarities in Handwriting Under a Two-Stage Evaluative Process*,†. J Forensic Sci. 2020 Nov; 65(6):2080-2086. Fuglsby C, Saunders C, Ommen DM, Caligiuri MP. PMID: 32835414.
      View in: PubMed   Mentions: 1     Fields:    
    6. Exploring the Relationship of Transdiagnostic Mood and Psychosis Symptom Domains with Motor Dysfunction. Neuropsychobiology. 2020; 79(4-5):301-312. Kent JS, Disner SG, Van Voorhis AC, Uroševic S, Caligiuri MP, Sponheim SR. PMID: 31851987; PMCID: PMC8500525.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    7. Handwriting Movement Abnormalities in Symptomatic and Premanifest Huntington's Disease. Mov Disord Clin Pract. 2019 Sep; 6(7):586-592. Caligiuri M, Snell C, Park S, Corey-Bloom J. PMID: 31538093; PMCID: PMC6749811.
      View in: PubMed   Mentions: 4     Fields:    
    8. Signature dynamics in Alzheimer's disease. Forensic Sci Int. 2019 Sep; 302:109880. Caligiuri MP, Mohammed L. PMID: 31390576; PMCID: PMC6910131.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    9. The nature of bradykinesia in schizophrenia treated with antipsychotics. Psychiatry Res. 2019 03; 273:537-543. Caligiuri MP, Teulings HL, Dean CE, Lohr JB. PMID: 30710809; PMCID: PMC6561794.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    10. Instrument-based assessment of motor function yields no evidence of dyskinesia in adult first-degree biological relatives of individuals with schizophrenia and schizoaffective disorder. Psychiatry Res. 2019 02; 272:135-140. Kent JS, Caligiuri MP, Skorheim MK, Lano TJ, Mittal VA, Sponheim SR. PMID: 30580137; PMCID: PMC6397690.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    11. A multisite study of performance drivers among institutional review boards. J Clin Transl Sci. 2017 Jun; 1(3):192-197. Caligiuri M, Allen K, Buscher N, Denney L, Gates C, Kantelo K, Magit A, Sak R, Firestein GS, Fontanesi J. PMID: 29093967; PMCID: PMC5652635.
      View in: PubMed   Mentions: 5  
    12. A quantitative measure of handwriting dysfluency for assessing tardive dyskinesia. J Clin Psychopharmacol. 2015 Apr; 35(2):168-74. Caligiuri MP, Teulings HL, Dean CE, Lohr JB. PMID: 25679121; PMCID: PMC4344392.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    13. Dynamic characteristics of signatures: effects of writer style on genuine and simulated signatures. J Forensic Sci. 2015 Jan; 60(1):89-94. Mohammed L, Found B, Caligiuri M, Rogers D. PMID: 25420668.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    14. Kinematics of signature writing in healthy aging. J Forensic Sci. 2014 Jul; 59(4):1020-4. Caligiuri MP, Kim C, Landy KM. PMID: 24673648; PMCID: PMC4077921.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    15. Handwriting analysis indicates spontaneous dyskinesias in neuroleptic naïve adolescents at high risk for psychosis. J Vis Exp. 2013 Nov 21; (81):e50852. Dean DJ, Teulings HL, Caligiuri M, Mittal VA. PMID: 24300590; PMCID: PMC3902788.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    16. Modafinil improves antipsychotic-induced parkinsonism but not excessive daytime sleepiness, psychiatric symptoms or cognition in schizophrenia and schizoaffective disorder: a randomized, double-blind, placebo-controlled study. Schizophr Res. 2013 Oct; 150(1):289-96. Lohr JB, Liu L, Caligiuri MP, Kash TP, May TA, Murphy JD, Ancoli-Israel S. PMID: 23938173.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    17. Nonadherence to the isochrony principle in forged signatures. Forensic Sci Int. 2012 Nov 30; 223(1-3):228-32. Caligiuri MP, Mohammed LA, Found B, Rogers D. PMID: 23084659.
      View in: PubMed   Mentions: 1     Fields:    
    18. Quantitative assessment of motor abnormalities in untreated patients with major depressive disorder. J Affect Disord. 2013 Mar 20; 146(1):84-90. Lohr JB, May T, Caligiuri MP. PMID: 22985485; PMCID: PMC4283485.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    19. Voxel-based morphometry of patients with schizophrenia or bipolar I disorder: a matched control study. Psychiatry Res. 2011 Nov 30; 194(2):149-56. Brown GG, Lee JS, Strigo IA, Caligiuri MP, Meloy MJ, Lohr J. PMID: 21924872; PMCID: PMC3196272.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    20. Associations between spontaneous movement abnormalities and psychotic-like experiences in the general population. Schizophr Res. 2011 Nov; 132(2-3):194-6. Mittal VA, Dean DJ, Pelletier A, Caligiuri M. PMID: 21782390; PMCID: PMC3195924.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    21. The dynamic character of disguise behavior for text-based, mixed, and stylized signatures. J Forensic Sci. 2011 Jan; 56 Suppl 1:S136-41. Mohammed LA, Found B, Caligiuri M, Rogers D. PMID: 20950317.
      View in: PubMed   Mentions:    Fields:    
    22. Handwriting movement kinematics for quantifying extrapyramidal side effects in patients treated with atypical antipsychotics. Psychiatry Res. 2010 May 15; 177(1-2):77-83. Caligiuri MP, Teulings HL, Dean CE, Niculescu AB, Lohr JB. PMID: 20381875; PMCID: PMC2859992.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    23. Identification of blood biomarkers for psychosis using convergent functional genomics. Mol Psychiatry. 2011 Jan; 16(1):37-58. Kurian SM, Le-Niculescu H, Patel SD, Bertram D, Davis J, Dike C, Yehyawi N, Lysaker P, Dustin J, Caligiuri M, Lohr J, Lahiri DK, Nurnberger JI, Faraone SV, Geyer MA, Tsuang MT, Schork NJ, Salomon DR, Niculescu AB. PMID: 19935739.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    24. Handwriting movement analyses for monitoring drug-induced motor side effects in schizophrenia patients treated with risperidone. Hum Mov Sci. 2009 Oct; 28(5):633-42. Caligiuri MP, Teulings HL, Dean CE, Niculescu AB, Lohr J. PMID: 19692133; PMCID: PMC2749075.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    25. Reformed consent: adapting to new media and research participant preferences. IRB. 2009 Mar-Apr; 31(2):1-8. Henry J, Palmer BW, Palinkas L, Glorioso DK, Caligiuri MP, Jeste DV. PMID: 19402337; PMCID: PMC2743865.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    26. Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia. J Clin Psychopharmacol. 2008 Feb; 28(1):69-73. Cortese L, Caligiuri MP, Williams R, Schieldrop P, Manchanda R, Malla A, Harricharan R. PMID: 18204344.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    27. Internal versus external: oral-motor performance as a function of attentional focus. J Speech Lang Hear Res. 2007 Feb; 50(1):131-6. Freedman SE, Maas E, Caligiuri MP, Wulf G, Robin DA. PMID: 17344554.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    28. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions. J Clin Psychopharmacol. 2006 Dec; 26(6):560-5. Dean CE, Kuskowski MA, Caligiuri MP. PMID: 17110811.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    29. PhenoChipping of psychotic disorders: a novel approach for deconstructing and quantitating psychiatric phenotypes. Am J Med Genet B Neuropsychiatr Genet. 2006 Sep 05; 141B(6):653-62. Niculescu AB, Lulow LL, Ogden CA, Le-Niculescu H, Salomon DR, Schork NJ, Caligiuri MP, Lohr JB. PMID: 16838358.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    30. Impaired hemispheric communication in schizophrenia: a study using the consonant-vowel-consonant task. Schizophr Res. 2006 Oct; 87(1-3):279-88. Lohr JB, Hellige JB, Cherry BJ, Lulow L, Kwok W, Caligiuri MP. PMID: 16822652.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    31. Quantitative measurement of handwriting in the assessment of drug-induced parkinsonism. Hum Mov Sci. 2006 Oct; 25(4-5):510-22. Caligiuri MP, Teulings HL, Filoteo JV, Song D, Lohr JB. PMID: 16647772.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    32. Striatopallidal regulation of affect in bipolar disorder. J Affect Disord. 2006 Apr; 91(2-3):235-42. Caligiuri MP, Brown GG, Meloy MJ, Eberson S, Niculescu AB, Lohr JB. PMID: 16503055.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    33. Pharmacogenetics for off-patent antipsychotics: reframing the risk for tardive dyskinesia and access to essential medicines. Expert Opin Pharmacother. 2006 Feb; 7(2):119-33. Ozdemir V, Aklillu E, Mee S, Bertilsson L, Albers LJ, Graham JE, Caligiuri M, Lohr JB, Reist C. PMID: 16433578.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    34. Abnormalities in motor physiology in bipolar disorder. J Neuropsychiatry Clin Neurosci. 2006; 18(3):342-9. Lohr JB, Caligiuri MP. PMID: 16963583.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    35. Do preclinical findings of methamphetamine-induced motor abnormalities translate to an observable clinical phenotype? Neuropsychopharmacology. 2005 Dec; 30(12):2125-34. Caligiuri MP, Buitenhuys C. PMID: 16123755.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    36. Lateralized cognitive dysfunction and psychotic symptoms in schizophrenia. Schizophr Res. 2005 Dec 15; 80(2-3):151-61. Caligiuri MP, Hellige JB, Cherry BJ, Kwok W, Lulow LL, Lohr JB. PMID: 16125374.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    37. Relationship of neuromotor disturbances to psychosis symptoms in first-episode neuroleptic-naive schizophrenia patients. Schizophr Res. 2005 Jun 01; 75(1):65-75. Cortese L, Caligiuri MP, Malla AK, Manchanda R, Takhar J, Haricharan R. PMID: 15820325.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    38. A portable hand-held device for quantifying and standardizing tremor assessment. J Med Eng Technol. 2004 Nov-Dec; 28(6):254-62. Caligiuri MP, Tripp RM. PMID: 15513743.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    39. A functional magnetic resonance imaging study of cortical asymmetry in bipolar disorder. Bipolar Disord. 2004 Jun; 6(3):183-96. Caligiuri MP, Brown GG, Meloy MJ, Eyler LT, Kindermann SS, Eberson S, Frank LR, Lohr JB. PMID: 15117397.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    40. Clinical rating scales and instruments: how do they compare in assessing abnormal, involuntary movements? J Clin Psychopharmacol. 2004 Jun; 24(3):298-304. Dean CE, Russell JM, Kuskowski MA, Caligiuri MP, Nugent SM. PMID: 15118484.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    41. Association of diabetes with dyskinesia in older psychosis patients. Psychopharmacology (Berl). 2004 Nov; 176(3-4):281-6. Caligiuri MP, Jeste DV. PMID: 15138754.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    42. Functional brain asymmetries during visuomotor tracking. J Clin Exp Neuropsychol. 2004 May; 26(3):356-68. Brown GG, Caligiuri M, Meloy MJ, Eberson SC, Kindermann SS, Frank LR, Eyler Zorrilla LT, Lohr JB. PMID: 15512926.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    43. A quantitative neuromotor predictor of antidepressant non-response in patients with major depression. J Affect Disord. 2003 Nov; 77(2):135-41. Caligiuri MP, Gentili V, Eberson S, Kelsoe J, Rapaport M, Gillin JC. PMID: 14607390.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsCTClinical Trials
    44. Neuromotor abnormalities and risk for psychosis in Alzheimer's disease. Neurology. 2003 Oct 14; 61(7):954-8. Caligiuri MP, Peavy G, Salmon DP, Galasko DR, Thal LJ. PMID: 14557567.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    45. An fMRI study of affective state and medication on cortical and subcortical brain regions during motor performance in bipolar disorder. Psychiatry Res. 2003 Jul 30; 123(3):171-82. Caligiuri MP, Brown GG, Meloy MJ, Eberson SC, Kindermann SS, Frank LR, Zorrilla LE, Lohr JB. PMID: 12928105.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    46. Treatment predictors of extrapyramidal side effects in patients with tardive dyskinesia: results from Veterans Affairs Cooperative Study 394. J Clin Psychopharmacol. 2002 Apr; 22(2):196-200. Lohr JB, Caligiuri MP, Edson R, Lavori P, Adler LA, Rotrosen J, Hitzemann R. PMID: 11910266.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    47. Extrapyramidal signs and cognitive abilities in Alzheimer's disease. Int J Geriatr Psychiatry. 2001 Sep; 16(9):907-11. Caligiuri MP, Peavy G, Galasko DR. PMID: 11571772.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    48. Relationship of gender and age at onset of schizophrenia to severity of dyskinesia. J Neuropsychiatry Clin Neurosci. 2001; 13(3):399-402. Lindamer LA, Lohr JB, Caligiuri MP, Jeste DV. PMID: 11514648.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    49. Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations. Drugs Aging. 2000 Nov; 17(5):363-84. Caligiuri MR, Jeste DV, Lacro JP. PMID: 11190417.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    50. Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study. Int J Geriatr Psychiatry. 2000 Sep; 15(9):794-802. Samuel W, Caligiuri M, Galasko D, Lacro J, Marini M, McClure FS, Warren K, Jeste DV. PMID: 10984725.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    51. Neuroleptic-induced striatal damage in rats: a study of antioxidant treatment using accelerometric and immunocytochemical methods. Psychopharmacology (Berl). 2000 Feb; 148(2):171-9. Lohr JB, Caligiuri MP, Manley MS, Browning JA. PMID: 10663432.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    52. Instrumentally detected changes in motor functioning in patients with low levels of antipsychotic dopamine D2 blockade. Neuropsychopharmacology. 2000 Jan; 22(1):19-26. Fitzgerald PB, Kapur S, Caligiuri MP, Jones C, Silvestri S, Remington G, Zipursky RB. PMID: 10633487.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    53. Motor and cognitive aspects of motor retardation in depression. J Affect Disord. 2000 Jan-Mar; 57(1-3):83-93. Caligiuri MP, Ellwanger J. PMID: 10708819.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    54. An instrumental study of the relationship between extrapyramidal signs and psychosis in Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 2000; 12(1):34-9. Caligiuri MP, Peavy G. PMID: 10678510.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    55. Vitamin E treatment for tardive dyskinesia. Veterans Affairs Cooperative Study #394 Study Group. Arch Gen Psychiatry. 1999 Sep; 56(9):836-41. Adler LA, Rotrosen J, Edson R, Lavori P, Lohr J, Hitzemann R, Raisch D, Caligiuri M, Tracy K. PMID: 12892048.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    56. Incidence and predictors of drug-induced parkinsonism in older psychiatric patients treated with very low doses of neuroleptics. J Clin Psychopharmacol. 1999 Aug; 19(4):322-8. Caligiuri MP, Lacro JP, Jeste DV. PMID: 10440459.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    57. Sleep-disordered breathing and periodic limb movements in sleep in older patients with schizophrenia. Biol Psychiatry. 1999 Jun 01; 45(11):1426-32. Ancoli-Israel S, Martin J, Jones DW, Caligiuri M, Patterson T, Harris MJ, Jeste DV. PMID: 10356624.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    58. Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients. J Am Geriatr Soc. 1999 Jun; 47(6):716-9. Jeste DV, Lacro JP, Bailey A, Rockwell E, Harris MJ, Caligiuri MP. PMID: 10366172.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    59. Incidence of tardive dyskinesia in early stages of low-dose treatment with typical neuroleptics in older patients. Am J Psychiatry. 1999 Feb; 156(2):309-11. Jeste DV, Lacro JP, Palmer B, Rockwell E, Harris MJ, Caligiuri MP. PMID: 9989570.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    60. Scaling of movement velocity: a measure of neuromotor retardation in individuals with psychopathology. Psychophysiology. 1998 Jul; 35(4):431-7. Caligiuri MP, Lohr JB, Ruck RK. PMID: 9643057.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    61. Adverse neurobiological effects of long-term use of neuroleptics: human and animal studies. J Psychiatr Res. 1998 May-Aug; 32(3-4):201-14. Jeste DV, Lohr JB, Eastham JH, Rockwell E, Caligiuri MP. PMID: 9793874.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    62. Extrapyramidal side effects in patients with Alzheimer's disease treated with low-dose neuroleptic medication. Am J Geriatr Psychiatry. 1998; 6(1):75-82. Caligiuri MP, Rockwell E, Jeste DV. PMID: 9469217.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    63. Lateralized hemispheric dysfunction in the major psychotic disorders: historical perspectives and findings from a study of motor asymmetry in older patients. Schizophr Res. 1997 Oct 30; 27(2-3):191-8. Lohr JB, Caligiuri MP. PMID: 9416648.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    64. Incidence and risk factors for severe tardive dyskinesia in older patients. Br J Psychiatry. 1997 Aug; 171:148-53. Caligiuri MP, Lacro JP, Rockwell E, McAdams LA, Jeste DV. PMID: 9337951.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    65. Reliability of an instrumental assessment of tardive dyskinesia: results from VA Cooperative Study #394. Psychopharmacology (Berl). 1997 Jul; 132(1):61-6. Caligiuri MP, Lohr JB, Rotrosen J, Adler L, Lavori P, Edson R, Tracy K. PMID: 9272760.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    66. An association between increased serum-soluble interleukin-2 receptors and a disturbance in muscle force in schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry. 1997 Jul; 21(5):817-27. Rapaport MH, Caligiuri MP, Lohr JB. PMID: 9278953.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    67. Instrumental motor predictors of neuroleptic-induced parkinsonism in newly medicated schizophrenia patients. J Neuropsychiatry Clin Neurosci. 1997; 9(4):562-7. Caligiuri MP, Lohr JB. PMID: 9447497.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    68. Tardive dyskinesia and positive and negative symptoms of schizophrenia. A study using instrumental measures. Br J Psychiatry. 1996 Jun; 168(6):702-8. Yuen O, Caligiuri MP, Williams R, Dickson RA. PMID: 8773812.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    69. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia. J Clin Psychiatry. 1996 Apr; 57(4):167-73. Lohr JB, Caligiuri MP. PMID: 8601552.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    70. Risk factors for orofacial and limbtruncal tardive dyskinesia in older patients: a prospective longitudinal study. Psychopharmacology (Berl). 1996 Feb; 123(4):307-14. Paulsen JS, Caligiuri MP, Palmer B, McAdams LA, Jeste DV. PMID: 8867868.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    71. Extrapyramidal motor signs in clinically diagnosed Alzheimer disease. Alzheimer Dis Assoc Disord. 1996; 10(2):103-14. Ellis RJ, Caligiuri M, Galasko D, Thal LJ. PMID: 8727172.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    72. Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients. Arch Gen Psychiatry. 1995 Sep; 52(9):756-65. Jeste DV, Caligiuri MP, Paulsen JS, Heaton RK, Lacro JP, Harris MJ, Bailey A, Fell RL, McAdams LA. PMID: 7654127.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    73. Fluctuation of tardive dyskinesia. Biol Psychiatry. 1995 Sep 01; 38(5):336-9. Caligiuri MP, Lohr JB, Vaughan RM, McAdams LA. PMID: 7495929.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    74. Motor asymmetry, a neurobiologic abnormality in the major psychoses. Psychiatry Res. 1995 Aug 28; 57(3):279-82. Lohr JB, Caligiuri MP. PMID: 7501739.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    75. Instrumental measures in geriatric psychopharmacology. Psychopharmacol Bull. 1995; 31(4):641-9. Lebowitz BD, Pollock BG, Caligiuri MP, Kluger A, Laghrissi-Thode F. PMID: 8851635.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    76. Metoclopramide and tardive dyskinesia. Biol Psychiatry. 1994 Nov 01; 36(9):630-2. Sewell DD, Kodsi AB, Caligiuri MP, Jeste DV. PMID: 7833431.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    77. A disturbance in the control of muscle force in neuroleptic-naive schizophrenic patients. Biol Psychiatry. 1994 Jan 15; 35(2):104-11. Caligiuri MP, Lohr JB. PMID: 7909452.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    78. Portable device for quantifying parkinsonian wrist rigidity. Mov Disord. 1994 Jan; 9(1):57-63. Caligiuri MP. PMID: 7908119.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    79. Early course of new-onset tardive dyskinesia in older patients. Psychopharmacol Bull. 1994; 30(2):187-91. Lacro JP, Gilbert PL, Paulsen JS, Fell R, Bailey A, Juels C, Caligiuri M, McAdams LA, Harris MJ, Jeste DV. PMID: 7831454.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    80. Parkinsonism in neuroleptic-naive schizophrenic patients. Am J Psychiatry. 1993 Sep; 150(9):1343-8. Caligiuri MP, Lohr JB, Jeste DV. PMID: 8352344.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    81. Worsening of postural tremor in patients with levodopa-induced dyskinesia: a quantitative analysis. Clin Neuropharmacol. 1993 Jun; 16(3):244-50. Caligiuri MP, Lohr JB. PMID: 8504441.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    82. Tardive dyskinesia. Schizophr Bull. 1993; 19(2):303-15. Jeste DV, Caligiuri MP. PMID: 8100643.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    83. A quantitative study of levodopa-induced dyskinesia in Parkinson's disease. J Neural Transm Park Dis Dement Sect. 1993; 6(2):89-98. Caligiuri MP, Peterson S. PMID: 8117413.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    84. Extrapyramidal motor abnormalities associated with late-life psychosis. Schizophr Bull. 1993; 19(4):747-54. Caligiuri MP, Lohr JB, Panton D, Harris MJ. PMID: 7905662.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    85. Metoclopramide-associated tardive dyskinesia in hemodialysis patients with diabetes mellitus. Two case reports. Gen Hosp Psychiatry. 1992 Nov; 14(6):416-9. Sewell DD, Yoshinobu BH, Caligiuri MP, Jeste DV. PMID: 1473712.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    86. Quantitative instrumental measurement of tardive dyskinesia: a review. Neuropsychopharmacology. 1992 Jun; 6(4):231-9. Lohr JB, Caligiuri MP. PMID: 1632892.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    87. Quantifying drug-induced changes in parkinsonian rigidity using an instrumental measure of activated stiffness. Clin Neuropharmacol. 1992 Feb; 15(1):1-12. Caligiuri MP, Galasko DR. PMID: 1576594.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    88. High incidence of tardive dyskinesia in older outpatients on low doses of neuroleptics. Psychopharmacol Bull. 1992; 28(1):87-92. Harris MJ, Panton D, Caligiuri MP, Krull AJ, Tran-Johnson TK, Jeste DV. PMID: 1609047.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    89. Sensorimotor disinhibition in Parkinson's disease: effects of levodopa. Ann Neurol. 1992 Jan; 31(1):53-8. Caligiuri MP, Heindel WC, Lohr JB. PMID: 1543350.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    90. Biological research in geriatric psychiatry. Biol Psychiatry. 1991 Nov 01; 30(9):855-6. Jeste DV, Caligiuri MP. PMID: 1747435.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    91. Instrumental evidence that age increases motor instability in neuroleptic-treated patients. J Gerontol. 1991 Sep; 46(5):B197-200. Caligiuri MP, Lohr JB, Jeste DV. PMID: 1679770.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    92. Clinical and instrumental assessment of neuroleptic-induced parkinsonism in patients with tardive dyskinesia. Biol Psychiatry. 1991 Jan 15; 29(2):139-48. Caligiuri MP, Lohr JB, Bracha HS, Jeste DV. PMID: 1671645.
      View in: PubMed   Mentions: 8     Fields:    
    93. Fine force instability: a quantitative measure of neuroleptic-induced dyskinesia in the hand. J Neuropsychiatry Clin Neurosci. 1990; 2(4):395-8. Caligiuri MP, Lohr JB. PMID: 1983784.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    94. Instrumental assessment of lingual motor instability in tardive dyskinesia. Neuropsychopharmacology. 1989 Dec; 2(4):309-12. Caligiuri MP, Jeste DV, Harris MJ. PMID: 2575388.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    95. Asymmetry of neuroleptic-induced rigidity: development of quantitative methods and clinical correlates. Psychiatry Res. 1989 Dec; 30(3):275-84. Caligiuri MP, Bracha HS, Lohr JB. PMID: 2575771.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    96. The influence of speaking rate on articulatory hypokinesia in parkinsonian dysarthria. Brain Lang. 1989 Apr; 36(3):493-502. Caligiuri MP. PMID: 2706450.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    97. A potential mechanism underlying the voluntary suppression of tardive dyskinesia. J Psychiatr Res. 1989; 23(3-4):257-66. Caligiuri MP, Lohr JB. PMID: 2576826.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    98. Quantitative analyses of voluntary orofacial motor control in schizophrenia and tardive dyskinesia. Biol Psychiatry. 1988 Nov; 24(7):787-800. Caligiuri MP, Harris MJ, Jeste DV. PMID: 2906545.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    99. Hypoglossal, trigeminal, and facial motoneuron involvement in amyotrophic lateral sclerosis. Neurology. 1988 Feb; 38(2):281-3. DePaul R, Abbs JH, Caligiuri M, Gracco VL, Brooks BR. PMID: 3340294.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    100. Response properties of the perioral reflex in Parkinson's disease. Exp Neurol. 1987 Dec; 98(3):563-72. Caligiuri MP, Abbs JH. PMID: 3678433.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    101. Labial kinematics during speech in patients with parkinsonian rigidity. Brain. 1987 Aug; 110 ( Pt 4):1033-44. Caligiuri MP. PMID: 3651793.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    102. Hormonal changes and enforced diving in the harbor seal Phoca vitulina. II. Plasma catecholamines. Am J Physiol. 1982 May; 242(5):R528-32. Hance AJ, Robin ED, Halter JB, Lewiston N, Robin DA, Cornell L, Caligiuri M, Theodore J. PMID: 7081478.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    Michael's Networks
    Concepts (283)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (18)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-8-gc1ed69da on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California